Companies/US/LIMN

LIMINATUS PHARMA, INC.

Last · —$3.25-0.16 (-4.69%)live · yahoo · 1h ago
Vol 20.1K ≈ 65.3K
Market cap$4.37M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session

Issuer

Legal nameLIMINATUS PHARMA, INC.
HQUnited States (US)
ListingUS LIMN
ISINUS53271X1081
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2836
CurrencyUSD
Entity registrysec:0001971387
CIK0001971387
Employees1
Loading chart…

Press & signals

3 recent
  • GlobeNewswire

    Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock

  • GlobeNewswire

    Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

  • GlobeNewswire

    Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline

Documents

FormReporting forFiledFlags
2026-06-302026-08-14 3
—2026-07-300